CMMB

CHEMOMAB THERAPEUTICS LTD

CMMB·16385C203·US·ADR·Healthcare - Biotechnology-Activist

CMMB (CHEMOMAB THERAPEUTICS LTD) is held by 7 institutional investors as of Q1 2026. Largest holders: CITADEL ADVISORS LLC ($100,766), XTX Topco Ltd ($29,248), RHUMBLINE ADVISERS ($28,832). Net institutional sentiment: Mixed.

7
Holders
Avg rating(1 Elite)
$200,450
Total Value
40% (10)
Fund Consensus
4 buying - 6 selling
CMMBSmart Money Verdict
View all
Held by 7 funds
1 elite
Who's Trading
InsiderMAMor George AdiBuy $10KMay 29, 2026
InsiderMAMor George AdiBuy $10KMay 29, 2026
ActivistPTPeter Thiel4.6%Feb 17, 2026
ActivistOEOtto Erik6.3%Feb 10, 2026
ActivistMorgan StanleyMorgan Stanley3.2%Aug 7, 2025
ActivistOIORBIMED ISRAEL BIOFUND GP LIMITED PARTNERSHIP4.8%Jun 23, 2025
ActivistSPSphera Funds Management Ltd.4.8%Apr 10, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Decreased
64,182(-38.2%)$100,7660.0%+6.10%
0
Decreased
18,629(-2.0%)$29,2480.0%+6.10%
0
Increased
18,366(+2.9%)$28,8320.0%-39.37%
14
New
13,491$21,1810.0%-2.79%
29
Increased
8,425(+3.7%)$13,2270.0%-63.55%
13
Increased
4,575(+21.2%)$7,1830.0%-59.06%
13
Decreased
8(-99.6%)$130.0%-3.66%
0
Exited
0(-100.0%)$18,0000.0%+9.15%
0
Exited
0(-100.0%)$30.0%+9.15%
0
Exited
0(-100.0%)$25,7370.0%-61.01%
0

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used